Esophageal irritation due to alendronate sodium tablets: Possible mechanisms

Digestive Diseases and Sciences

Volumn 43, Issue 9, 1998, Pages 1998-2002

  Peter, C P ^a   Handt, L K ^a   Smith, S M ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Bisphosphonate; Gastrointestinal irritation

Indexed keywords

ALENDRONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DISEASE ASSOCIATION; DOG; DOSE RESPONSE; ESOPHAGITIS; ESOPHAGUS DISEASE; ESOPHAGUS FUNCTION; ESOPHAGUS INJURY; NONHUMAN; OSTEOPOROSIS; PH; PRIORITY JOURNAL;

ALENDRONATE; ANIMALS; BONE RESORPTION; DIPHOSPHONATES; DOGS; ESOPHAGUS; ETIDRONIC ACID; MUCOUS MEMBRANE;

EID: 0031671019     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018894827961     Document Type: Article

References (10)

1. Liberman UA, Weiss SA, Broll J, Minne HW, Quan H, Bell NH, Rodriguez-Portales J, Downs RW, Dequeker J, Farus M, Seeman E, Recker RR, Capizi T, Santora AC, Lombardi A, Shaw R, Hirsch LJ, Karpf DB: Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. N Engl J Med 333:1437-1443, 1995
2. Black DM, Cummings SR, Karpf DB, Cauley JA, Thompson DE, Nevitt MC, Bauer DC, Grenant HK, Haskell WL, Marcus R, OH SM, Torner JR, Quandt SA, Reiss TF, Ensrud KE: Randomized trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 348:1535-1541, 1996
3. Didronel (etidronate disodium): US Physician's Circular, Procter and Gamble Pharmaceuticals, The Physician's Desk Reference 1996, pp. 1984-1986
4. Saunders RL Jr: Appearance of a gastric ulcer during diphosphonate therapy in a woman with CRST syndrome. South Med J 70:1327-1329, 1977
5. Lufkin EG, Argueta R, Whitaker MD, Cameron AL, Wong V, Egan KS, O'Fallon WM, Riggs BL: Pamidronate: An unrecognized problem in gastrointestinal tolerability. Osteoporosis Int 4:320-322, 1994
6. Reginster JYL: Oral tiludronate: Pharmacological properties and potential usefulness in Paget's disease of bone and osteoporosis. Bone 13:351-354, 1992
7. De Grouen PC, Lubbe DF, Hirsch LJ, Daifotis A, Stephenson W, Freedholm D, Pryor-Tollotson S, Seleznick MJ, Pinkas H, Wang KK: Esophagitis associated with the use of alendronate. N Engl J Med 335:1016-1021, 1996
8. Olovson GS, Bjorkman JA, Ek L, Hauu N: The ulcerogenic effect on the esophagus of three β-adrenoceptor antagonists, investigated in a new porcine esophagus test model. Acta Pharmacol Toxicol 53:385-391, 1983
9. Ryrfeldt A, Norbeck K, Reiland S, Moldeus P: Drug-induced esophageal lesions studied in vitro. Acta Physiol Scand Suppl 592:73-82, 1990
10. Bozymski EM, Isaacs KL: Medications reported to cause esophageal damage. In T Yamada (ed). Textbook of Gastroenterology, 2nd ed., Vol. 1. Philadelphia, JB Lippincott, 1995, pp 1283-1301